Finding 1136328 (2024-002)

Material Weakness Repeat Finding
Requirement
AB
Questioned Costs
$1
Year
2024
Accepted
2025-05-08
Audit: 355815
Organization: Firstfollowers (IL)

AI Summary

  • Core Issue: There is a significant weakness in internal controls, leading to a lack of documentation for management's review and approval of grant expenses.
  • Impacted Requirements: This finding violates CFR § 200.303(a), which mandates effective internal controls to ensure compliance with federal award terms.
  • Recommended Follow-Up: Improve internal controls by ensuring all expenses have proper documentation and management approval before accessing grant funds.

Finding Text

Federal agency: U.S. Treasury Federal program title: Coronavirus State and Local Fiscal Recovery Funds Assistance Listing Number: 21.027 Pass-Through Agency: City of Champaign, Illinois; Champaign County, Illinois; City of Urbana, Illinois Pass-Through Number(s): 20220245; 02220246; 2224-FF-CO Award Period: 7/1/2023-12/31/2026; 3/1/2023-12/30/2023; 12/15/2023-12/31/2024; 3/1/2022-12/31/2023; 3/1/2022-12/31/2024 Type of Finding: Material Weakness in Internal Control over Compliance and Other Matter Criteria or Specific Requirement: Code of Federal Regulations (CFR) § 200.303(a) indicates nonfederal entities must establish and maintain effective internal control over the Federal award that provides reasonable assurance that the nonfederal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States or the “Internal Control Integrated Framework,” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Condition: Lack of supporting documentation showing management's review and approval of costs as being allowable under the grant terms. Also, an expense was charged to the grant in error. Questioned costs: $16. Context: For 36 of the 60 allowable general disbursement cost transactions selected for testing, there was no documentation showing management's review and approval of the expense as being allowable. For 1 of the 60 general disbursement costs transactions selected for testing, it was charged to the grant in error, causing it to be a questioned cost. Cause: Error by management when reviewing the expenses to document their review on the invoice or other supporting documentation. Effect: If costs are not reviewed and approved as being allowable, it could result in unallowable costs being charged to federal grants. Repeat Finding: Repeat Finding of 2023-005. Recommendation: We recommend the Organization enhance its internal controls in order to require the maintaining of appropriate supporting documentation to show the review and approval of expenses charged to grants, prior to drawing down grant funds. Views of responsible officials: The Organization will continue to review all documentation and ensure proper signatures accompany the documentation going forward.

Categories

Questioned Costs Allowable Costs / Cost Principles

Other Findings in this Audit

  • 559878 2024-002
    Material Weakness Repeat
  • 559879 2024-003
    Material Weakness Repeat
  • 559880 2024-004
    Significant Deficiency Repeat
  • 559881 2024-005
    Significant Deficiency
  • 559882 2024-002
    Material Weakness Repeat
  • 559883 2024-003
    Material Weakness Repeat
  • 559884 2024-004
    Significant Deficiency Repeat
  • 559885 2024-005
    Significant Deficiency
  • 559886 2024-002
    Material Weakness Repeat
  • 559887 2024-003
    Material Weakness Repeat
  • 559888 2024-004
    Significant Deficiency Repeat
  • 559889 2024-005
    Significant Deficiency
  • 559890 2024-002
    Material Weakness Repeat
  • 559891 2024-003
    Material Weakness Repeat
  • 559892 2024-004
    Significant Deficiency Repeat
  • 559893 2024-005
    Significant Deficiency
  • 1136320 2024-002
    Material Weakness Repeat
  • 1136321 2024-003
    Material Weakness Repeat
  • 1136322 2024-004
    Significant Deficiency Repeat
  • 1136323 2024-005
    Significant Deficiency
  • 1136324 2024-002
    Material Weakness Repeat
  • 1136325 2024-003
    Material Weakness Repeat
  • 1136326 2024-004
    Significant Deficiency Repeat
  • 1136327 2024-005
    Significant Deficiency
  • 1136329 2024-003
    Material Weakness Repeat
  • 1136330 2024-004
    Significant Deficiency Repeat
  • 1136331 2024-005
    Significant Deficiency
  • 1136332 2024-002
    Material Weakness Repeat
  • 1136333 2024-003
    Material Weakness Repeat
  • 1136334 2024-004
    Significant Deficiency Repeat
  • 1136335 2024-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.239 Home Investment Partnerships Program $55,600
21.027 Coronavirus State and Local Fiscal Recovery Funds $54,900